Scientists train Patients' own cells to hunt deadly breast cancer
NCT ID NCT05989828
Summary
This early-phase study is testing a personalized cell therapy for advanced triple-negative breast cancer that has returned or stopped responding to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to recognize cancer, and infuse them back to attack tumors. The main goals are to find a safe dose and understand side effects in about 20 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
Conditions
Explore the condition pages connected to this study.